Section I Benign Cutaneous Melanocytic Proliferations
1. Melanotic Macules
2. Acquired Melanocytic Nevi
3. Congenital Melanocytic Nevi
4. Spitz Nevi
5. Blue Nevi and Dermal Melanocytosis
6. Deep Penetrating Nevi
7. Nevi of Special Cutaneous Sites
8. Traumatized and Recurrent Melanocytic Nevi, and Nevi Changing under Treatment
9. Combined Melanocytic Nevi
10. Pigmented Epithelioid Melanocytoma
Section II Primary Cutaneous Melanoma
11. Histopathologic Fiagnosis of Melanoma
12. Lentigo Maligna Melanoma
13. Superficial Spreading Melanoma
14. Acral and Subungual Melanoma
15. Nodular Melanoma
16. Desmoplastic Melanoma
17. Nevoid Melanoma
18. Spitzoid Melanoma
19. Melanoma Arising in Association with or Simulating a Blue Nevus
20. Uncommon Variants of Melanoma
21. Pediatric Melanoma
Section III Primary Extracutaneous Melanocytic Proliferations
22. Conjunctival Melanocytic Proliferations
23. Melanocytic Proliferations of the Uveal Tract
24. Mucosal Melanocytic Tumors
25. Primary Melanocytic Neoplasms of the Central Nervous System and Melanotic Schwannoma
26. Melanocytic nevi in Lymph Nodes
Section IV Metastatic Melanoma
27. Metastatic Melanoma
Section V Ancillary Studies
28. Dermoscopy for Dermatopathologists
29. Immunohistochemistry for the Diagnosis of Melanocytic Proliferations
30. Molecular Techniques
31. Clinical, Dermoscopic, Pathologic and Molecular Correlations
Section VI Prognosis, Staging, and Reporting of Melanoma
32. Prognosis, Staging, and Reporting of Melanoma
Section VII Margin Assessment of Melanomas
33. Margin Assessment of Cutaneous Melanoma
Dr. Klaus Busam is a Professor of Pathology at Memorial Sloan Kettering Cancer Center and the Director of the combined Memorial Sloan Kettering/Cornell Dermatopathology Training Program. His training is from the Brigham & Women's Hospital and Harvard Medical School combined program. His interests include the utilization of clinical, histological and molecular diagnostic methods to optimize diagnostic accuracy and best predict the behavior of melanocytic neoplasms. As a dermatopathologist, he is recognized as an international expert in the diagnosis of melanoma and is sent many second opinion cases both from within and outside of the United States. As a researcher he is focused on developing molecular based methods to improve the diagnosis and prognostication of melanocytic neoplasms. He has authored over 250 peer reviewed journal articles and numerous textbooks in dermatopathology.
Dr Pedram Gerami: Selected to Best Doctors in America 2019-2020, Dr Gerami is the director of the Skin Cancer Institute of Northwestern Medical Group (SCIN-Med) and the director of the Melanoma Program in the Skin Cancer Institute and the Melanoma clinic in the department of Dermatology. His clinical and research interests are primarily focused on melanoma skin cancer, atypical nevi and borderline melanocytic tumors such as Spitz tumors which may be difficult to classify. As a dermatologist, dermatopathologist and researcher focused in the care of patients with melanoma and atypical nevi, he has a unique perspective on the behavior of melanocytic neoplasms.